- Galapagos Genomics
Galapagos Genomics NV is a biotech company located in
Mechelen ,Belgium . The company was founded in1999 as a joint venture betweenCrucell (formerly IntroGene) andTibotec . The company has its own internal discovery programs which it combines with drug discovery and pre-clinical service activities for other biotech and pharmaceutical companies.Onno van de Stolpe is the CEO of the company.The company uses a technological platform for its research, which is based on adenoviruses to introduce human gene sequences into a wide variety of human cell lines to
knock-in orknock-down specificproteins .References
* Edwards PJ., The impact of parallel chemistry in drug discovery, IDrugs. 2006 May;9(5):347-53.
ee also
*
FlandersBio ource
* [http://www.nieuwsblad.be/Article/Detail.aspx?articleID=g23e5cag Galapagos Genomics gaat zelf medicijnen ontwikkelen] (Dutch)
* [http://www.trends.be/nl/4-1380-39886/een-rotsvast-geloof-in-de-vlaamse-biotech.html Een rotsvast geloof in de Vlaamse biotech]External links
* [http://web.galapagos.be/ Galapagos Genomics]
Wikimedia Foundation. 2010.